HUE061008T2 - Policiklusos aromás amin radioizotóppal jelzett kvaterner ammóniumsója, a radioaktív izotóppal jelzett vegyület használata pozitronemissziós tomográfia (pet) diagnosztikai eljárásban, valamint a policiklusos aromás amin radioaktív izotóppal jelzett kvaterner ammóniumsó vegyületét tartalmazó gyógyszerészeti készítmény - Google Patents
Policiklusos aromás amin radioizotóppal jelzett kvaterner ammóniumsója, a radioaktív izotóppal jelzett vegyület használata pozitronemissziós tomográfia (pet) diagnosztikai eljárásban, valamint a policiklusos aromás amin radioaktív izotóppal jelzett kvaterner ammóniumsó vegyületét tartalmazó gyógyszerészeti készítményInfo
- Publication number
- HUE061008T2 HUE061008T2 HUE19786404A HUE19786404A HUE061008T2 HU E061008 T2 HUE061008 T2 HU E061008T2 HU E19786404 A HUE19786404 A HU E19786404A HU E19786404 A HUE19786404 A HU E19786404A HU E061008 T2 HUE061008 T2 HU E061008T2
- Authority
- HU
- Hungary
- Prior art keywords
- radiolabelled compound
- quaternary ammonium
- ammonium salt
- aromatic amine
- polycyclic aromatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL426916A PL239871B1 (pl) | 2018-09-05 | 2018-09-05 | Znakowany radioizotopem związek czwartorzędowej soli amoniowej wielopierścieniowej aminy aromatycznej, zastosowanie znakowanego radioizotopem związku w metodzie diagnostycznej pozytonowej tomografii emisyjnej, a także kompozycja farmaceutyczna zawierająca znakowany radioizotopem związek czwartorzędowej soli amoniowej wielopierścieniowej aminy aromatycznej |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE061008T2 true HUE061008T2 (hu) | 2023-06-28 |
Family
ID=68208328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE19786404A HUE061008T2 (hu) | 2018-09-05 | 2019-09-04 | Policiklusos aromás amin radioizotóppal jelzett kvaterner ammóniumsója, a radioaktív izotóppal jelzett vegyület használata pozitronemissziós tomográfia (pet) diagnosztikai eljárásban, valamint a policiklusos aromás amin radioaktív izotóppal jelzett kvaterner ammóniumsó vegyületét tartalmazó gyógyszerészeti készítmény |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210338847A1 (hu) |
| EP (1) | EP3814325B1 (hu) |
| JP (1) | JP7438197B2 (hu) |
| DK (1) | DK3814325T3 (hu) |
| ES (1) | ES2938415T3 (hu) |
| FI (1) | FI3814325T3 (hu) |
| HU (1) | HUE061008T2 (hu) |
| PL (1) | PL239871B1 (hu) |
| WO (1) | WO2020050729A1 (hu) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4062849A (en) | 1968-05-02 | 1977-12-13 | Produits Chimiques Ugine Kuhlmann | Perfluoroalkylene quaternary heterocyclic nitrogen salts |
| US8524193B2 (en) * | 2002-02-06 | 2013-09-03 | The Johns Hopkins University | Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
| WO2011084585A2 (en) | 2009-12-16 | 2011-07-14 | Washington University | Dihydroethidine analogues and uses thereof |
| WO2018207193A1 (en) * | 2017-05-11 | 2018-11-15 | Hadasit Medical Research Services And Development Ltd. | Radiolabeled compounds that target organic cation transporters and uses thereof in radioimaging |
-
2018
- 2018-09-05 PL PL426916A patent/PL239871B1/pl unknown
-
2019
- 2019-09-04 HU HUE19786404A patent/HUE061008T2/hu unknown
- 2019-09-04 DK DK19786404.4T patent/DK3814325T3/da active
- 2019-09-04 ES ES19786404T patent/ES2938415T3/es active Active
- 2019-09-04 EP EP19786404.4A patent/EP3814325B1/en active Active
- 2019-09-04 FI FIEP19786404.4T patent/FI3814325T3/fi active
- 2019-09-04 WO PCT/PL2019/000073 patent/WO2020050729A1/en unknown
- 2019-09-04 JP JP2021513279A patent/JP7438197B2/ja active Active
- 2019-09-04 US US17/273,647 patent/US20210338847A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK3814325T3 (da) | 2023-01-30 |
| FI3814325T3 (fi) | 2023-03-01 |
| EP3814325A1 (en) | 2021-05-05 |
| ES2938415T3 (es) | 2023-04-10 |
| EP3814325B1 (en) | 2022-11-30 |
| WO2020050729A1 (en) | 2020-03-12 |
| JP2021536495A (ja) | 2021-12-27 |
| JP7438197B2 (ja) | 2024-02-26 |
| PL426916A1 (pl) | 2020-03-09 |
| US20210338847A1 (en) | 2021-11-04 |
| PL239871B1 (pl) | 2022-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY179696A (en) | Compositions and methods comprising bupropion or related compounds and dextromethorphan | |
| EP3324975A4 (en) | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT, AND METHOD OF USE THEREOF | |
| PT3634965T (pt) | Radiofarmacêuticos, agentes de radioimagiologia, e suas utilizações | |
| MX2020012969A (es) | Combinacion y composicion farmaceutica y preparacion combinada que contiene activador de glucocinasa y farmaco hipoglucemico biguanida, asi como metodo de preparacion y uso del mismo. | |
| WO2015153772A3 (en) | Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography | |
| PL3805198T3 (pl) | Związek, jego sól i cząstki lipidowe | |
| EP3919476A4 (en) | QUATERNARY AMMONIUM SALT COMPOUND, METHOD FOR PREPARATION AND USE | |
| ZA202000491B (en) | Peptide amide compounds, preparation method thereof and use in medicine | |
| IL290768A (en) | Systems and methods for accurate and fast positron emission tomography using deep learning | |
| PT3421038T (pt) | Compostos de naftiridina, combinações médicas e sua utilização | |
| SG11201908281VA (en) | Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof | |
| IL276871A (en) | Pure bupropion dosage forms and methods for enantiomeric distortion purposes | |
| IL285378A (en) | A heterocyclic compound, a medical preparation containing it, a method for its preparation, and its use | |
| EP4023659A4 (en) | COMPOUND AND DRUG CONJUGATE, PRODUCTION METHOD AND USE THEREOF | |
| JP2018502150A5 (hu) | ||
| HUE061008T2 (hu) | Policiklusos aromás amin radioizotóppal jelzett kvaterner ammóniumsója, a radioaktív izotóppal jelzett vegyület használata pozitronemissziós tomográfia (pet) diagnosztikai eljárásban, valamint a policiklusos aromás amin radioaktív izotóppal jelzett kvaterner ammóniumsó vegyületét tartalmazó gyógyszerészeti készítmény | |
| EP3741105A4 (en) | DENTAL IMAGING WITHOUT IONIZING RADIATION THROUGH NEAR-INFRARED FLUORESCENCE AND RELATED SYSTEMS | |
| HK1251463A1 (zh) | 一種用於醫學成像的組合物及其製備方法 | |
| ZA202000265B (en) | Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound | |
| GB201910294D0 (en) | Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine phosphate | |
| EP3733670A4 (en) | TETRAHYDROPYRROL COMPOUND, METHOD OF MANUFACTURE THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | |
| IL284432A (en) | A preparation for magnetic resonance imaging containing sarcosine containing deuterium, and a diagnostic method using the aforementioned preparation | |
| IL284132A (en) | A pharmaceutical compound, a method for its preparation and its use as a medicinal substance | |
| IL282999A (en) | 4,3,1-oxadiazolone compound and drug | |
| EP3743110C0 (en) | MRNA MOLECULE AND PHOTOSENSITIZATION AGENT FOR MEDICAL USE |